Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Lingyue Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3040-8627; OpenAlex author ID A5014180007. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Targeting SLC6A14-mediated nutrient competition reverses an immunosuppressive metabolic niche in pancreatic cancer. Co-author DOI 10.1186/s40164-026-00818-9↗
  2. Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer. Co-author DOI 10.1038/s41467-025-63146-2↗
  3. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci187024↗
  4. Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy. Co-author DOI 10.1186/s13046-022-02273-w↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 4 shared papers, 2022–2026 · strength 0.80
  2. Xueli Bai · 4 shared papers, 2022–2026 · strength 0.80
  3. Lihong He · 3 shared papers, 2025–2026 · strength 0.64
  4. Xiaozhen Zhang · 2 shared papers, 2025–2026 · strength 0.47
  5. Hanshen Yang · 2 shared papers, 2025 · strength 0.36
  6. Xiongbin Lu · 2 shared papers, 2025 · strength 0.36
  7. Kang Sun · 2 shared papers, 2025 · strength 0.36
  8. Mengyi Lao · 2 shared papers, 2025 · strength 0.36
  9. Jinyuan Song · 2 shared papers, 2022–2025 · strength 0.33
  10. Junming Huang · 1 shared paper, 2025 · strength 0.19
  11. Xinyuan Liu · 1 shared paper, 2025 · strength 0.19
  12. Yan Chen · 1 shared paper, 2025 · strength 0.19
  13. Xiao Zhi · 1 shared paper, 2025 · strength 0.17
  14. Xiang Li Ma · 1 shared paper, 2025 · strength 0.17
  15. Mao Ye · 1 shared paper, 2025 · strength 0.17
  16. Xing Huang · 1 shared paper, 2022 · strength 0.16
  17. Jiaqi Yang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.